

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 9.19827759 |
| 2 | nucleobase catabolic process (GO:0046113) | 7.22037119 |
| 3 | establishment of nucleus localization (GO:0040023) | 6.86248662 |
| 4 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 6.51102934 |
| 5 | axon extension involved in axon guidance (GO:0048846) | 6.51102934 |
| 6 | cell migration in hindbrain (GO:0021535) | 5.36697124 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.28727646 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 5.08783194 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.02520614 |
| 10 | cranial nerve morphogenesis (GO:0021602) | 4.97888951 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.94328677 |
| 12 | vocalization behavior (GO:0071625) | 4.78050845 |
| 13 | * neurotransmitter secretion (GO:0007269) | 4.73620622 |
| 14 | axon extension (GO:0048675) | 4.65815233 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.57506356 |
| 16 | thyroid gland development (GO:0030878) | 4.49076740 |
| 17 | retinal ganglion cell axon guidance (GO:0031290) | 4.47945434 |
| 18 | axon cargo transport (GO:0008088) | 4.43682356 |
| 19 | urinary tract smooth muscle contraction (GO:0014848) | 4.43078233 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.35337026 |
| 21 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.35165563 |
| 22 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.33595688 |
| 23 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.32812872 |
| 24 | neurofilament cytoskeleton organization (GO:0060052) | 4.30465656 |
| 25 | intermediate filament cytoskeleton organization (GO:0045104) | 4.22341584 |
| 26 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.21001297 |
| 27 | negative chemotaxis (GO:0050919) | 4.20527507 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.19455897 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 4.13523474 |
| 30 | exploration behavior (GO:0035640) | 4.11545449 |
| 31 | central nervous system neuron axonogenesis (GO:0021955) | 4.08442479 |
| 32 | peristalsis (GO:0030432) | 4.08203497 |
| 33 | intermediate filament-based process (GO:0045103) | 4.07719561 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.03924376 |
| 35 | respiratory system process (GO:0003016) | 3.99626782 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.96876475 |
| 37 | neuronal action potential propagation (GO:0019227) | 3.95790900 |
| 38 | prepulse inhibition (GO:0060134) | 3.95232643 |
| 39 | nucleus localization (GO:0051647) | 3.94800289 |
| 40 | facial nerve structural organization (GO:0021612) | 3.91099221 |
| 41 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.90309952 |
| 42 | mitochondrion transport along microtubule (GO:0047497) | 3.90309952 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.88712267 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.83385666 |
| 45 | establishment of mitochondrion localization (GO:0051654) | 3.82745872 |
| 46 | neuron projection extension (GO:1990138) | 3.81453533 |
| 47 | negative regulation of axon extension (GO:0030517) | 3.81035945 |
| 48 | ganglion development (GO:0061548) | 3.80054541 |
| 49 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.76706557 |
| 50 | activation of protein kinase A activity (GO:0034199) | 3.76124942 |
| 51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.75658592 |
| 52 | positive regulation of fibroblast migration (GO:0010763) | 3.72647387 |
| 53 | intermediate filament organization (GO:0045109) | 3.68312141 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.65613745 |
| 55 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.64675344 |
| 56 | startle response (GO:0001964) | 3.64351643 |
| 57 | negative regulation of axon guidance (GO:1902668) | 3.62778500 |
| 58 | protein localization to synapse (GO:0035418) | 3.62559913 |
| 59 | glycine transport (GO:0015816) | 3.60129715 |
| 60 | regulation of axon guidance (GO:1902667) | 3.59281647 |
| 61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.58765861 |
| 62 | synaptic transmission, dopaminergic (GO:0001963) | 3.57529132 |
| 63 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.57392678 |
| 64 | neuron recognition (GO:0008038) | 3.57333669 |
| 65 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.56183899 |
| 66 | neuron-neuron synaptic transmission (GO:0007270) | 3.56031497 |
| 67 | * neurotransmitter transport (GO:0006836) | 3.54763469 |
| 68 | cranial nerve structural organization (GO:0021604) | 3.53717743 |
| 69 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.53374674 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.52832733 |
| 71 | dendritic spine morphogenesis (GO:0060997) | 3.52061548 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 3.51143254 |
| 73 | * regulation of neurotransmitter levels (GO:0001505) | 3.50876089 |
| 74 | axon regeneration (GO:0031103) | 3.49927056 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 3.46251695 |
| 76 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.44845367 |
| 77 | regulation of axon extension (GO:0030516) | 3.42497643 |
| 78 | neuromuscular process controlling balance (GO:0050885) | 3.40766799 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 3.39964880 |
| 80 | regulation of protein kinase A signaling (GO:0010738) | 3.35945122 |
| 81 | dendrite morphogenesis (GO:0048813) | 3.35222856 |
| 82 | glutamate receptor signaling pathway (GO:0007215) | 3.34333278 |
| 83 | striatum development (GO:0021756) | 3.33783949 |
| 84 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.31468765 |
| 85 | membrane hyperpolarization (GO:0060081) | 3.30963257 |
| 86 | response to auditory stimulus (GO:0010996) | 3.30952780 |
| 87 | layer formation in cerebral cortex (GO:0021819) | 3.28699658 |
| 88 | glutamate secretion (GO:0014047) | 3.26982288 |
| 89 | neurotransmitter catabolic process (GO:0042135) | 3.24751603 |
| 90 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.24703752 |
| 91 | motor neuron axon guidance (GO:0008045) | 3.24167188 |
| 92 | auditory behavior (GO:0031223) | 3.22591342 |
| 93 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21177035 |
| 94 | neuronal ion channel clustering (GO:0045161) | 3.20279401 |
| 95 | axonal fasciculation (GO:0007413) | 3.20257484 |
| 96 | adult walking behavior (GO:0007628) | 3.19359969 |
| 97 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.18972545 |
| 98 | proline transport (GO:0015824) | 3.16787482 |
| 99 | endothelial cell differentiation (GO:0045446) | 3.16068772 |
| 100 | anterograde axon cargo transport (GO:0008089) | 3.14300642 |
| 101 | positive regulation of axonogenesis (GO:0050772) | 3.12979699 |
| 102 | axon development (GO:0061564) | 3.12941524 |
| 103 | regulation of female receptivity (GO:0045924) | 3.12880492 |
| 104 | regulation of extent of cell growth (GO:0061387) | 3.12879920 |
| 105 | negative regulation of axonogenesis (GO:0050771) | 3.11969302 |
| 106 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.11475542 |
| 107 | negative regulation of microtubule polymerization (GO:0031115) | 3.09824628 |
| 108 | presynaptic membrane assembly (GO:0097105) | 3.09562062 |
| 109 | dopamine receptor signaling pathway (GO:0007212) | 3.09304217 |
| 110 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.08293512 |
| 111 | presynaptic membrane organization (GO:0097090) | 3.08046182 |
| 112 | innervation (GO:0060384) | 3.07204205 |
| 113 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 3.07082916 |
| 114 | postsynaptic membrane organization (GO:0001941) | 3.06608910 |
| 115 | apical protein localization (GO:0045176) | 3.06485299 |
| 116 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.05950226 |
| 117 | negative regulation of amino acid transport (GO:0051956) | 3.05573195 |
| 118 | amino acid import (GO:0043090) | 3.05329263 |
| 119 | neuromuscular process (GO:0050905) | 3.04643382 |
| 120 | regulation of respiratory system process (GO:0044065) | 3.03098812 |
| 121 | synaptic transmission, glutamatergic (GO:0035249) | 3.02505090 |
| 122 | regulation of axonogenesis (GO:0050770) | 3.02412502 |
| 123 | lateral sprouting from an epithelium (GO:0060601) | 3.01831155 |
| 124 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00712324 |
| 125 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.00437938 |
| 126 | positive regulation of axon extension (GO:0045773) | 2.99041010 |
| 127 | behavioral response to nicotine (GO:0035095) | 2.97903609 |
| 128 | regulation of vesicle fusion (GO:0031338) | 2.96665744 |
| 129 | peripheral nervous system neuron development (GO:0048935) | 2.95959636 |
| 130 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.95176838 |
| 131 | regulation of glutamate secretion (GO:0014048) | 2.94240813 |
| 132 | regulation of neurotransmitter uptake (GO:0051580) | 2.94172456 |
| 133 | respiratory tube development (GO:0030323) | 2.93357849 |
| 134 | long-term synaptic potentiation (GO:0060291) | 2.90665189 |
| 135 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.90511119 |
| 136 | regulation of dopamine secretion (GO:0014059) | 2.89747433 |
| 137 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.88562391 |
| 138 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.88562391 |
| 139 | positive regulation of neurotransmitter transport (GO:0051590) | 2.88171816 |
| 140 | behavioral fear response (GO:0001662) | 2.87561273 |
| 141 | behavioral defense response (GO:0002209) | 2.87561273 |
| 142 | * neuromuscular synaptic transmission (GO:0007274) | 2.86654569 |
| 143 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.85455514 |
| 144 | cAMP catabolic process (GO:0006198) | 2.84869537 |
| 145 | synapse assembly (GO:0007416) | 2.83194233 |
| 146 | regulation of postsynaptic membrane potential (GO:0060078) | 2.81469984 |
| 147 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.81365575 |
| 148 | positive regulation of synaptic transmission (GO:0050806) | 2.81000599 |
| 149 | regulation of respiratory gaseous exchange (GO:0043576) | 2.80983294 |
| 150 | long-term memory (GO:0007616) | 2.80389170 |
| 151 | synapse organization (GO:0050808) | 2.80304516 |
| 152 | positive regulation of membrane potential (GO:0045838) | 2.78949720 |
| 153 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.78305480 |
| 154 | positive regulation of synapse assembly (GO:0051965) | 2.77837637 |
| 155 | female mating behavior (GO:0060180) | 2.75036498 |
| 156 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74818884 |
| 157 | behavioral response to cocaine (GO:0048148) | 2.74199139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.15712699 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.40270903 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23214986 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.20947702 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11810259 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.96952194 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.96952194 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.83292690 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.82586230 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.75189858 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.70762750 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64512187 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62112649 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50239038 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.49204585 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.44564670 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39806988 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.33234958 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29664374 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29300583 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.27000392 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.21838957 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21631709 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.20669281 |
| 25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.19724275 |
| 26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.19724275 |
| 27 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.19724275 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10253868 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04644522 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04564510 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.02801249 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94609472 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.93691753 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92990183 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.89320827 |
| 36 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.82643489 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75046671 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64395480 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63738857 |
| 40 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61753558 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59242166 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58772886 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54714449 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53952869 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49958183 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46727186 |
| 47 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.45119895 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42133617 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.41140871 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38802410 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36743099 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33538465 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31817641 |
| 54 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31580368 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31439293 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30484657 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29402825 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29349081 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27093545 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25960301 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25278863 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24007967 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23915194 |
| 64 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.22482388 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20538091 |
| 66 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20394482 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19819797 |
| 68 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.19797314 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18997671 |
| 70 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18904428 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.16712052 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16385730 |
| 73 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16096584 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15994723 |
| 75 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14202627 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12770120 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12628413 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11918999 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11161154 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11087389 |
| 81 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10923932 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10163356 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10045250 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07942412 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05216144 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04870250 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03656595 |
| 88 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03486473 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03087479 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02913435 |
| 91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02209916 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01087479 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01043758 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00950788 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00852606 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00388753 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99562997 |
| 98 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99383427 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98751031 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98649437 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98415068 |
| 102 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98359986 |
| 103 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97448560 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97339735 |
| 105 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96592724 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94462918 |
| 107 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94274751 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94050970 |
| 109 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93960620 |
| 110 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93237623 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.92886722 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92644798 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92321916 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92210858 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92112184 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91782213 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91436698 |
| 118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91436698 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91216303 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91029414 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90930138 |
| 122 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.90893504 |
| 123 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90803767 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90714139 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90043289 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89285537 |
| 127 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89065745 |
| 128 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.86864440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.69387052 |
| 2 | MP0003880_abnormal_central_pattern | 4.04355496 |
| 3 | MP0002822_catalepsy | 3.94082928 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.69948766 |
| 5 | MP0009745_abnormal_behavioral_response | 3.30009860 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.01070512 |
| 7 | MP0002064_seizures | 2.98397176 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.86098678 |
| 9 | MP0009046_muscle_twitch | 2.68145399 |
| 10 | MP0004142_abnormal_muscle_tone | 2.67800080 |
| 11 | MP0002272_abnormal_nervous_system | 2.59248445 |
| 12 | MP0001486_abnormal_startle_reflex | 2.50766632 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.43435248 |
| 14 | MP0004270_analgesia | 2.41324721 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.35340416 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.29253334 |
| 17 | MP0001529_abnormal_vocalization | 2.27244962 |
| 18 | MP0002249_abnormal_larynx_morphology | 2.19461943 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.18240228 |
| 20 | MP0003122_maternal_imprinting | 2.09959927 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.98088368 |
| 22 | * MP0002184_abnormal_innervation | 1.97522359 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.97411711 |
| 24 | MP0001348_abnormal_lacrimal_gland | 1.92756324 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.91012091 |
| 26 | * MP0000955_abnormal_spinal_cord | 1.87145460 |
| 27 | MP0005409_darkened_coat_color | 1.86540124 |
| 28 | MP0002751_abnormal_autonomic_nervous | 1.76862260 |
| 29 | * MP0002734_abnormal_mechanical_nocicepti | 1.73944286 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.69095023 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.64719880 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.62379150 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.61523979 |
| 34 | * MP0001970_abnormal_pain_threshold | 1.61068328 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.58292323 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.57781777 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.57404379 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.57142940 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.54305037 |
| 40 | MP0004924_abnormal_behavior | 1.54305037 |
| 41 | MP0002736_abnormal_nociception_after | 1.52360452 |
| 42 | MP0008569_lethality_at_weaning | 1.51522760 |
| 43 | MP0005248_abnormal_Harderian_gland | 1.51110511 |
| 44 | MP0000778_abnormal_nervous_system | 1.48933251 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.44038598 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.42134532 |
| 47 | MP0000537_abnormal_urethra_morphology | 1.40244946 |
| 48 | MP0000579_abnormal_nail_morphology | 1.40156718 |
| 49 | MP0003787_abnormal_imprinting | 1.39559469 |
| 50 | MP0003283_abnormal_digestive_organ | 1.38066375 |
| 51 | * MP0002882_abnormal_neuron_morphology | 1.33098997 |
| 52 | MP0001177_atelectasis | 1.31136537 |
| 53 | MP0002932_abnormal_joint_morphology | 1.30658952 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.29716749 |
| 55 | MP0001299_abnormal_eye_distance/ | 1.29560787 |
| 56 | MP0004885_abnormal_endolymph | 1.27673608 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.23811385 |
| 58 | MP0003861_abnormal_nervous_system | 1.23215773 |
| 59 | MP0003938_abnormal_ear_development | 1.20785988 |
| 60 | MP0002928_abnormal_bile_duct | 1.20678267 |
| 61 | MP0001188_hyperpigmentation | 1.19820593 |
| 62 | MP0003329_amyloid_beta_deposits | 1.19630031 |
| 63 | MP0001346_abnormal_lacrimal_gland | 1.17492685 |
| 64 | MP0004858_abnormal_nervous_system | 1.15158722 |
| 65 | MP0003942_abnormal_urinary_system | 1.13912250 |
| 66 | MP0003011_delayed_dark_adaptation | 1.13017150 |
| 67 | MP0003633_abnormal_nervous_system | 1.12651423 |
| 68 | MP0000751_myopathy | 1.10364015 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.10109052 |
| 70 | MP0002114_abnormal_axial_skeleton | 1.09914621 |
| 71 | MP0002108_abnormal_muscle_morphology | 1.09904999 |
| 72 | MP0005171_absent_coat_pigmentation | 1.09041888 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 1.08180159 |
| 74 | MP0000681_abnormal_thyroid_gland | 1.08061549 |
| 75 | MP0003690_abnormal_glial_cell | 1.07240789 |
| 76 | MP0000534_abnormal_ureter_morphology | 1.04518597 |
| 77 | * MP0002081_perinatal_lethality | 1.04240558 |
| 78 | MP0002735_abnormal_chemical_nociception | 1.03822332 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 1.03607536 |
| 80 | MP0000003_abnormal_adipose_tissue | 1.03106431 |
| 81 | MP0001984_abnormal_olfaction | 1.02149475 |
| 82 | MP0001905_abnormal_dopamine_level | 1.01517311 |
| 83 | MP0000538_abnormal_urinary_bladder | 1.00584819 |
| 84 | MP0000462_abnormal_digestive_system | 0.99212008 |
| 85 | MP0003385_abnormal_body_wall | 0.99115860 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.98872937 |
| 87 | MP0001664_abnormal_digestion | 0.98457185 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.97536727 |
| 89 | MP0003634_abnormal_glial_cell | 0.96086930 |
| 90 | MP0002102_abnormal_ear_morphology | 0.95834518 |
| 91 | MP0003879_abnormal_hair_cell | 0.95744501 |
| 92 | MP0009053_abnormal_anal_canal | 0.93220202 |
| 93 | MP0003631_nervous_system_phenotype | 0.90713328 |
| 94 | MP0002152_abnormal_brain_morphology | 0.89206248 |
| 95 | MP0005187_abnormal_penis_morphology | 0.89002691 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.87723213 |
| 97 | MP0005275_abnormal_skin_tensile | 0.87575037 |
| 98 | MP0002090_abnormal_vision | 0.86780023 |
| 99 | MP0002282_abnormal_trachea_morphology | 0.86604302 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.85431965 |
| 101 | * MP0002752_abnormal_somatic_nervous | 0.85209627 |
| 102 | MP0004085_abnormal_heartbeat | 0.85144867 |
| 103 | MP0002082_postnatal_lethality | 0.84841598 |
| 104 | MP0010770_preweaning_lethality | 0.84841598 |
| 105 | MP0002177_abnormal_outer_ear | 0.84356066 |
| 106 | MP0005257_abnormal_intraocular_pressure | 0.82864235 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.82651328 |
| 108 | MP0004742_abnormal_vestibular_system | 0.82392430 |
| 109 | MP0003119_abnormal_digestive_system | 0.82087235 |
| 110 | MP0008874_decreased_physiological_sensi | 0.81487585 |
| 111 | MP0003632_abnormal_nervous_system | 0.79925432 |
| 112 | MP0000920_abnormal_myelination | 0.78504509 |
| 113 | MP0004130_abnormal_muscle_cell | 0.76242876 |
| 114 | MP0004134_abnormal_chest_morphology | 0.75989860 |
| 115 | MP0004145_abnormal_muscle_electrophysio | 0.75239290 |
| 116 | MP0002116_abnormal_craniofacial_bone | 0.75089830 |
| 117 | * MP0001943_abnormal_respiration | 0.74798826 |
| 118 | MP0010769_abnormal_survival | 0.74453903 |
| 119 | MP0008004_abnormal_stomach_pH | 0.71827548 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.71098218 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.70887605 |
| 122 | MP0002229_neurodegeneration | 0.70461181 |
| 123 | MP0010768_mortality/aging | 0.70431845 |
| 124 | MP0000026_abnormal_inner_ear | 0.70176907 |
| 125 | MP0000467_abnormal_esophagus_morphology | 0.69046344 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.67853228 |
| 127 | MP0005535_abnormal_body_temperature | 0.67704887 |
| 128 | MP0004233_abnormal_muscle_weight | 0.67362467 |
| 129 | MP0003121_genomic_imprinting | 0.66984026 |
| 130 | MP0009250_abnormal_appendicular_skeleto | 0.66360884 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.61587682 |
| 132 | MP0001963_abnormal_hearing_physiology | 0.61285461 |
| 133 | MP0004272_abnormal_basement_membrane | 0.60407722 |
| 134 | MP0008872_abnormal_physiological_respon | 0.59440442 |
| 135 | MP0005499_abnormal_olfactory_system | 0.59194207 |
| 136 | MP0005394_taste/olfaction_phenotype | 0.59194207 |
| 137 | MP0004215_abnormal_myocardial_fiber | 0.59021839 |
| 138 | MP0001958_emphysema | 0.58227201 |
| 139 | MP0003123_paternal_imprinting | 0.57775429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.62652647 |
| 2 | Ulnar claw (HP:0001178) | 6.10470305 |
| 3 | Focal motor seizures (HP:0011153) | 5.69345925 |
| 4 | Focal seizures (HP:0007359) | 5.03670988 |
| 5 | Atonic seizures (HP:0010819) | 4.40045375 |
| 6 | Aqueductal stenosis (HP:0002410) | 4.33711726 |
| 7 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.03377184 |
| 8 | Febrile seizures (HP:0002373) | 3.65577776 |
| 9 | Partial agenesis of the corpus callosum (HP:0001338) | 3.55317517 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.51880755 |
| 11 | Cortical dysplasia (HP:0002539) | 3.49340149 |
| 12 | Morphological abnormality of the pyramidal tract (HP:0002062) | 3.43773653 |
| 13 | Poor suck (HP:0002033) | 3.35504238 |
| 14 | Torticollis (HP:0000473) | 3.32119851 |
| 15 | Abnormal eating behavior (HP:0100738) | 3.24875674 |
| 16 | Abnormality of the musculature of the hand (HP:0001421) | 3.20515910 |
| 17 | Generalized hypotonia (HP:0001290) | 3.16798988 |
| 18 | Pheochromocytoma (HP:0002666) | 3.16500157 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.15894843 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.15794010 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.13782001 |
| 22 | Ankle clonus (HP:0011448) | 3.09690987 |
| 23 | Action tremor (HP:0002345) | 3.08785529 |
| 24 | Absence seizures (HP:0002121) | 3.06886090 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.04820386 |
| 26 | Absent septum pellucidum (HP:0001331) | 2.97497147 |
| 27 | Neurofibrillary tangles (HP:0002185) | 2.97463251 |
| 28 | Pachygyria (HP:0001302) | 2.97156145 |
| 29 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.95362152 |
| 30 | Hypoplasia of the brainstem (HP:0002365) | 2.95362152 |
| 31 | Anxiety (HP:0000739) | 2.90221499 |
| 32 | Visual hallucinations (HP:0002367) | 2.83492336 |
| 33 | Steppage gait (HP:0003376) | 2.82851067 |
| 34 | Resting tremor (HP:0002322) | 2.77685253 |
| 35 | Dialeptic seizures (HP:0011146) | 2.77164385 |
| 36 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.76292535 |
| 37 | Amyotrophic lateral sclerosis (HP:0007354) | 2.75136471 |
| 38 | Craniofacial dystonia (HP:0012179) | 2.72540394 |
| 39 | Hypoventilation (HP:0002791) | 2.72339066 |
| 40 | Abnormality of the septum pellucidum (HP:0007375) | 2.72012486 |
| 41 | Neuroendocrine neoplasm (HP:0100634) | 2.71793119 |
| 42 | Gait imbalance (HP:0002141) | 2.68748916 |
| 43 | Focal dystonia (HP:0004373) | 2.67940835 |
| 44 | Onion bulb formation (HP:0003383) | 2.63794864 |
| 45 | Hyperventilation (HP:0002883) | 2.62430699 |
| 46 | Decreased motor nerve conduction velocity (HP:0003431) | 2.60880827 |
| 47 | Lissencephaly (HP:0001339) | 2.58228962 |
| 48 | Depression (HP:0000716) | 2.57576429 |
| 49 | Microglossia (HP:0000171) | 2.51912171 |
| 50 | Hyperthyroidism (HP:0000836) | 2.49705053 |
| 51 | Amblyopia (HP:0000646) | 2.48803077 |
| 52 | Mutism (HP:0002300) | 2.47922271 |
| 53 | Abnormality of the foot musculature (HP:0001436) | 2.46045801 |
| 54 | Polyphagia (HP:0002591) | 2.46008744 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.45507270 |
| 56 | Limb dystonia (HP:0002451) | 2.45223742 |
| 57 | Failure to thrive in infancy (HP:0001531) | 2.44700486 |
| 58 | Broad-based gait (HP:0002136) | 2.44229011 |
| 59 | Urinary urgency (HP:0000012) | 2.43265744 |
| 60 | Foot dorsiflexor weakness (HP:0009027) | 2.41959503 |
| 61 | Impaired social interactions (HP:0000735) | 2.40656728 |
| 62 | Abnormal social behavior (HP:0012433) | 2.40656728 |
| 63 | Oligomenorrhea (HP:0000876) | 2.39688604 |
| 64 | Premature rupture of membranes (HP:0001788) | 2.39251543 |
| 65 | Adducted thumb (HP:0001181) | 2.38598608 |
| 66 | Dysmetria (HP:0001310) | 2.38240818 |
| 67 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.36879590 |
| 68 | Postural instability (HP:0002172) | 2.29539268 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.29180598 |
| 70 | Exotropia (HP:0000577) | 2.29085285 |
| 71 | Abnormality of salivation (HP:0100755) | 2.26148771 |
| 72 | Poor eye contact (HP:0000817) | 2.24829378 |
| 73 | Spastic paraplegia (HP:0001258) | 2.19556263 |
| 74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19113612 |
| 75 | Paraplegia (HP:0010550) | 2.18210898 |
| 76 | Buphthalmos (HP:0000557) | 2.16829647 |
| 77 | Protrusio acetabuli (HP:0003179) | 2.16625549 |
| 78 | Lower limb amyotrophy (HP:0007210) | 2.13488029 |
| 79 | Hypercortisolism (HP:0001578) | 2.11910436 |
| 80 | Spastic gait (HP:0002064) | 2.11220785 |
| 81 | Excessive salivation (HP:0003781) | 2.10506802 |
| 82 | Drooling (HP:0002307) | 2.10506802 |
| 83 | Akinesia (HP:0002304) | 2.08125196 |
| 84 | Insidious onset (HP:0003587) | 2.07197688 |
| 85 | Termporal pattern (HP:0011008) | 2.07197688 |
| 86 | Intention tremor (HP:0002080) | 2.05965002 |
| 87 | Truncal ataxia (HP:0002078) | 2.05904437 |
| 88 | Abnormality of the lower motor neuron (HP:0002366) | 2.05005703 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04237889 |
| 90 | Sacral dimple (HP:0000960) | 2.04116380 |
| 91 | Morphological abnormality of the middle ear (HP:0008609) | 2.03208397 |
| 92 | Ankyloglossia (HP:0010296) | 2.02563463 |
| 93 | Narrow nasal bridge (HP:0000446) | 2.02078783 |
| 94 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99700109 |
| 95 | Abnormality of the corticospinal tract (HP:0002492) | 1.99306724 |
| 96 | Hypsarrhythmia (HP:0002521) | 1.99266336 |
| 97 | Epileptiform EEG discharges (HP:0011182) | 1.98203552 |
| 98 | Absent speech (HP:0001344) | 1.95663389 |
| 99 | Myelomeningocele (HP:0002475) | 1.95372280 |
| 100 | Inappropriate behavior (HP:0000719) | 1.95367343 |
| 101 | Papilledema (HP:0001085) | 1.93944144 |
| 102 | Pointed chin (HP:0000307) | 1.93256037 |
| 103 | Hemiplegia (HP:0002301) | 1.92482799 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.92145247 |
| 105 | Spastic tetraplegia (HP:0002510) | 1.90390385 |
| 106 | Macroorchidism (HP:0000053) | 1.89954495 |
| 107 | Hammertoe (HP:0001765) | 1.89909357 |
| 108 | Scanning speech (HP:0002168) | 1.89808737 |
| 109 | Abnormality of pain sensation (HP:0010832) | 1.89471734 |
| 110 | Impaired pain sensation (HP:0007328) | 1.89471734 |
| 111 | Genetic anticipation (HP:0003743) | 1.88434272 |
| 112 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.86109986 |
| 113 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.83834197 |
| 114 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.83834197 |
| 115 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83214604 |
| 116 | Midline defect of the nose (HP:0004122) | 1.83010398 |
| 117 | Abnormality of the calcaneus (HP:0008364) | 1.82857201 |
| 118 | Gaze-evoked nystagmus (HP:0000640) | 1.82382070 |
| 119 | Apathy (HP:0000741) | 1.81210824 |
| 120 | Annular pancreas (HP:0001734) | 1.80471996 |
| 121 | Bradykinesia (HP:0002067) | 1.78697911 |
| 122 | Incomplete penetrance (HP:0003829) | 1.78594657 |
| 123 | Agitation (HP:0000713) | 1.75906930 |
| 124 | Hyperacusis (HP:0010780) | 1.75380044 |
| 125 | Abnormality of binocular vision (HP:0011514) | 1.75303924 |
| 126 | Diplopia (HP:0000651) | 1.75303924 |
| 127 | Spastic tetraparesis (HP:0001285) | 1.75055161 |
| 128 | Delayed gross motor development (HP:0002194) | 1.74626863 |
| 129 | Postural tremor (HP:0002174) | 1.74411148 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74155572 |
| 131 | Septo-optic dysplasia (HP:0100842) | 1.73915120 |
| 132 | Hypoplasia of the corpus callosum (HP:0002079) | 1.73771393 |
| 133 | Blue irides (HP:0000635) | 1.73418603 |
| 134 | Fetal akinesia sequence (HP:0001989) | 1.72226562 |
| 135 | Ventricular fibrillation (HP:0001663) | 1.72036409 |
| 136 | Bladder diverticulum (HP:0000015) | 1.71944965 |
| 137 | Bowel diverticulosis (HP:0005222) | 1.71913760 |
| 138 | Distal sensory impairment (HP:0002936) | 1.71855412 |
| 139 | Megalencephaly (HP:0001355) | 1.70867172 |
| 140 | Striae distensae (HP:0001065) | 1.70751115 |
| 141 | Prolonged QT interval (HP:0001657) | 1.69634096 |
| 142 | Abnormal EKG (HP:0003115) | 1.68897698 |
| 143 | Polymicrogyria (HP:0002126) | 1.68545294 |
| 144 | Vaginal atresia (HP:0000148) | 1.67945200 |
| 145 | Aplasia involving bones of the extremities (HP:0009825) | 1.67553219 |
| 146 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.67553219 |
| 147 | Aplasia of the phalanges of the hand (HP:0009802) | 1.67553219 |
| 148 | Overgrowth (HP:0001548) | 1.67508857 |
| 149 | Gait ataxia (HP:0002066) | 1.63404164 |
| 150 | Clonus (HP:0002169) | 1.63194695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.89008381 |
| 2 | NTRK3 | 3.86100169 |
| 3 | EPHA4 | 3.83381372 |
| 4 | MINK1 | 3.60258886 |
| 5 | CASK | 3.12546714 |
| 6 | DYRK2 | 2.90247948 |
| 7 | FES | 2.87532499 |
| 8 | TYRO3 | 2.84942225 |
| 9 | MAP3K4 | 2.71558457 |
| 10 | MAP3K9 | 2.55331373 |
| 11 | MAP3K12 | 2.36515801 |
| 12 | NTRK2 | 2.03765890 |
| 13 | MAP2K7 | 2.03620120 |
| 14 | TRIM28 | 1.87007349 |
| 15 | MAP2K4 | 1.80247024 |
| 16 | TNIK | 1.65337687 |
| 17 | MAPK13 | 1.60088617 |
| 18 | BCR | 1.60054332 |
| 19 | NTRK1 | 1.54885190 |
| 20 | PAK6 | 1.52112238 |
| 21 | PRKCG | 1.51676357 |
| 22 | CAMKK1 | 1.47398716 |
| 23 | SIK2 | 1.46356185 |
| 24 | KSR2 | 1.45719215 |
| 25 | LIMK1 | 1.44170205 |
| 26 | CDK5 | 1.35778714 |
| 27 | LMTK2 | 1.28432942 |
| 28 | PRKD3 | 1.26120179 |
| 29 | LATS2 | 1.26037313 |
| 30 | PHKG2 | 1.25145656 |
| 31 | PHKG1 | 1.25145656 |
| 32 | UHMK1 | 1.24805369 |
| 33 | DAPK2 | 1.24262575 |
| 34 | WNK1 | 1.23774245 |
| 35 | PAK3 | 1.22560573 |
| 36 | STK38 | 1.17995847 |
| 37 | GRK5 | 1.14491781 |
| 38 | PRKCE | 1.13642660 |
| 39 | DDR2 | 1.11011248 |
| 40 | PLK2 | 1.08669857 |
| 41 | CAMK2A | 1.08416855 |
| 42 | PRKCH | 1.07586129 |
| 43 | CAMK1G | 1.07329956 |
| 44 | TNK2 | 1.01679511 |
| 45 | KSR1 | 0.97347554 |
| 46 | DYRK1A | 0.96391061 |
| 47 | MAP3K2 | 0.94274789 |
| 48 | CAMK2G | 0.93877556 |
| 49 | SGK223 | 0.93033590 |
| 50 | SGK494 | 0.93033590 |
| 51 | MKNK2 | 0.92900752 |
| 52 | RET | 0.87866995 |
| 53 | IRAK2 | 0.84393784 |
| 54 | PINK1 | 0.83467590 |
| 55 | PDGFRA | 0.81770635 |
| 56 | MAP3K6 | 0.81526113 |
| 57 | GRK7 | 0.81457541 |
| 58 | ADRBK1 | 0.80681074 |
| 59 | CDK14 | 0.78724869 |
| 60 | BMPR1B | 0.78245257 |
| 61 | FER | 0.77891604 |
| 62 | PRKCZ | 0.76954326 |
| 63 | ROCK1 | 0.76784822 |
| 64 | MAP2K1 | 0.74351107 |
| 65 | MARK2 | 0.74150382 |
| 66 | NEK1 | 0.73765631 |
| 67 | TAF1 | 0.72911073 |
| 68 | ALK | 0.72300432 |
| 69 | PDGFRB | 0.68636264 |
| 70 | CSF1R | 0.67492915 |
| 71 | SGK2 | 0.67459089 |
| 72 | ERBB3 | 0.67081399 |
| 73 | MAPK15 | 0.66744146 |
| 74 | DAPK1 | 0.66692698 |
| 75 | CDK15 | 0.66666708 |
| 76 | EPHB2 | 0.66504186 |
| 77 | SGK3 | 0.65803460 |
| 78 | CDK18 | 0.65533739 |
| 79 | WNK3 | 0.65356173 |
| 80 | MKNK1 | 0.64890325 |
| 81 | CAMK2B | 0.64657540 |
| 82 | CDC42BPA | 0.64405203 |
| 83 | FGFR2 | 0.63238219 |
| 84 | FYN | 0.63224272 |
| 85 | CSNK1E | 0.62642271 |
| 86 | PNCK | 0.60801961 |
| 87 | ROCK2 | 0.60088206 |
| 88 | CAMKK2 | 0.59618640 |
| 89 | STK24 | 0.58306728 |
| 90 | CSNK1A1L | 0.57303982 |
| 91 | INSRR | 0.56743025 |
| 92 | RPS6KA3 | 0.54758359 |
| 93 | STK11 | 0.53900041 |
| 94 | MAPK4 | 0.53745095 |
| 95 | RIPK4 | 0.53733259 |
| 96 | CAMK2D | 0.53592049 |
| 97 | CDK11A | 0.53032698 |
| 98 | CSNK1G3 | 0.52729780 |
| 99 | TGFBR1 | 0.52293214 |
| 100 | IRAK1 | 0.52163702 |
| 101 | ADRBK2 | 0.51928693 |
| 102 | AKT3 | 0.50915499 |
| 103 | CSNK1G2 | 0.50304052 |
| 104 | SIK1 | 0.49806354 |
| 105 | SGK1 | 0.48586350 |
| 106 | PRKCB | 0.47628812 |
| 107 | PASK | 0.47188842 |
| 108 | CAMK1 | 0.46624125 |
| 109 | TRIB3 | 0.46245953 |
| 110 | RPS6KB1 | 0.46168092 |
| 111 | ERBB2 | 0.45729833 |
| 112 | SIK3 | 0.44939731 |
| 113 | CDK19 | 0.44528224 |
| 114 | MAPK9 | 0.43871938 |
| 115 | CSNK1G1 | 0.43693208 |
| 116 | TAOK1 | 0.42876060 |
| 117 | EEF2K | 0.42430711 |
| 118 | MAPK10 | 0.41705948 |
| 119 | FRK | 0.40050538 |
| 120 | PDPK1 | 0.39993569 |
| 121 | SCYL2 | 0.39437501 |
| 122 | SRC | 0.38168293 |
| 123 | RPS6KA2 | 0.38144834 |
| 124 | PKN1 | 0.37773665 |
| 125 | EIF2AK2 | 0.37169337 |
| 126 | ICK | 0.36416022 |
| 127 | PRKACB | 0.36193398 |
| 128 | MAPK8 | 0.35908303 |
| 129 | INSR | 0.35312315 |
| 130 | PIK3CA | 0.34873961 |
| 131 | EPHA3 | 0.34547678 |
| 132 | PRKACA | 0.34532226 |
| 133 | DYRK1B | 0.34406660 |
| 134 | PRKG1 | 0.32363927 |
| 135 | MAP3K5 | 0.31558149 |
| 136 | ILK | 0.30868070 |
| 137 | CAMK1D | 0.30599328 |
| 138 | RIPK1 | 0.30559502 |
| 139 | TESK1 | 0.28846054 |
| 140 | PRKAA1 | 0.28830849 |
| 141 | NME1 | 0.27990168 |
| 142 | PRKDC | 0.27955508 |
| 143 | CSNK1D | 0.25104774 |
| 144 | GSK3B | 0.22662068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.33863364 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.96782931 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.71475024 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57198440 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.36564495 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28293966 |
| 7 | * Cholinergic synapse_Homo sapiens_hsa04725 | 2.23133647 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15171308 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.08494565 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99867047 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.97690500 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.95395405 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.93364071 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 1.90791129 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84514577 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.81026427 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.75262538 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.63575398 |
| 19 | Gap junction_Homo sapiens_hsa04540 | 1.59759908 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58009884 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.54560222 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52086516 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50355594 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50246822 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49570358 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.49035486 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.41729202 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38861892 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30367152 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.30246581 |
| 31 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.29430622 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26698833 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.26492864 |
| 34 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24302246 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.20337836 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19742436 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19629262 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19544428 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19153305 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.18063904 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16868082 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16427555 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15468682 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13419389 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08473502 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.06163832 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04421022 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03392077 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02503823 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.99877525 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99550035 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99065938 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99037183 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95104461 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94599062 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93237647 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92551698 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92172256 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.91963083 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.90702978 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90490337 |
| 62 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.89471579 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89150022 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87984986 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86395628 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85378052 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.84307388 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84109423 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77506183 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73512205 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.72852936 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72771525 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72496525 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72138441 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68466086 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68367210 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67665954 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67341228 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65567400 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65450199 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65408092 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64644031 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.64205396 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61620943 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59567839 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58916280 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58743628 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58588068 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58075531 |
| 90 | Melanoma_Homo sapiens_hsa05218 | 0.57219376 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.56867272 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56543874 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55919138 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55346347 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55203913 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55049752 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54558981 |
| 98 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54443112 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54259835 |
| 100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53895966 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53583328 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.53176219 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50566063 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50102381 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49865921 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48712328 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48577456 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.48189888 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48092005 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47701537 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47162287 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.46820418 |
| 113 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46254707 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45901258 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45868288 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45807554 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45159919 |
| 118 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45014269 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44449725 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.41215917 |
| 121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38865281 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38334906 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37701299 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36841958 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.36521192 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36402439 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35007656 |

